Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.

Piñero F, Costa P, Boteon YL, Duque SH, Marciano S, Anders M, Varón A, Zerega A, Poniachik J, Soza A, Padilla Machaca M, Menéndez J, Zapata R, Vilatoba M, Muñoz L, Maraschio M, Podestá LG, McCormack L, Gadano A, Boin ISFF, García P, Silva M; Latin American Liver Research, Education, Awareness Network (LALREAN).

Clin Res Hepatol Gastroenterol. 2018 May 14. pii: S2210-7401(18)30074-3. doi: 10.1016/j.clinre.2018.03.014. [Epub ahead of print]

PMID:
29773419
2.

Hepatitis A outbreak since November 2016 affecting men who have sex with men (MSM) in Chile connected to the current outbreak in MSM in Europe, situation up to October 2017.

Rivas V, Barrera A, Pino K, Núñez R, Caceres CJ, Lopez-Lastra M, Soza A.

Euro Surveill. 2018 Mar;23(9). doi: 10.2807/1560-7917.ES.2018.23.9.18-00060.

3.

[Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients].

Vargas JI, Arab JP, Monrroy H, Labbé P, Sarmiento V, Fuster F, Barrera F, Benitez C, Arrese M, Fuster F, Soza A.

Rev Med Chil. 2017 Oct;145(10):1235-1242. doi: 10.4067/S0034-98872017001001235. Spanish. No abstract available.

4.

Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.

Piñero F, Costa P, Boteon YL, Duque SH, Marciano S, Anders M, Varón A, Zerega A, Poniachik J, Soza A, Machaca MP, Menéndez J, Zapata R, Vilatoba M, Muñoz L, Maraschio M, Fauda M, McCormack L, Gadano A, Boin IS, García JHP, Silva M.

Ann Hepatol. 2018 Mar 1;17(2):256-267. doi: 10.5604/01.3001.0010.8648.

5.

Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients.

Candia R, Norero B, Agüero C, Díaz L, Ortega JP, Wolff R, Hernández-Rocha C, Duarte I, Soza A, Benítez C, Arrese M.

Ann Hepatol. 2017 Sep-Oct;16(5):772-779. doi: 10.5604/01.3001.0010.2787.

6.

Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe.

Monrroy H, López-Lastra M, Soza A.

Med Hypotheses. 2017 May;102:51-55. doi: 10.1016/j.mehy.2017.03.016. Epub 2017 Mar 9.

PMID:
28478831
7.

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.

Mendizabal M, Haddad L, Gallardo PE, Ferrada A, Soza AA, Adrover R, Aravena E, Roblero JP, Prieto J, Vujacich C, Romero G, Muñoz A, Anders M, Hernández N, Coccozella D, Gruz F, Reggiardo MV, Ruf AE, Varón A, Cartier M, Pérez Ravier R, Ridruejo E, Peralta M, Poncino D, Vorobioff J, Aballay Soteras G, Silva MO.

J Med Virol. 2017 Sep;89(9):1590-1596. doi: 10.1002/jmv.24816. Epub 2017 Jun 6.

PMID:
28370222
8.

Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.

Arab JP, Hernández-Rocha C, Morales C, Vargas JI, Solís N, Pizarro M, Robles C, Sandoval D, Ponthus S, Benítez C, Barrera F, Soza A, Riquelme A, Arrese M.

Gastroenterol Hepatol. 2017 Jun - Jul;40(6):388-394. doi: 10.1016/j.gastrohep.2017.02.009. Epub 2017 Mar 28. English, Spanish.

PMID:
28359548
9.

Detection of high biliary and fecal viral loads in patients with chronic hepatitis C virus infection.

Monrroy H, Angulo J, Pino K, Labbé P, Miquel JF, López-Lastra M, Soza A.

Gastroenterol Hepatol. 2017 May;40(5):339-347. doi: 10.1016/j.gastrohep.2017.01.004. Epub 2017 Feb 27. English, Spanish.

PMID:
28249699
10.

 Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key.

Norero B, Serrano CA, Sanchez-Fueyo A, Duarte I, Torres J, Ocquetau M, Barrera F, Arrese M, Soza A, Benítez C.

Ann Hepatol. 2017 Jan-Feb 2017;16(1):94-106. doi: 10.5604/16652681.1226820.

11.

 Effect of ezetimibe in HCV viral load after liver transplantation.

Monrroy-Bravo H, Angulo J, Pino K, Labbé P, López-Lastra M, Soza A.

Ann Hepatol. 2016 Sep-Oct;15(5):803-5. doi: 10.5604/16652681.1212623. No abstract available.

12.

Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.

Piñero F, Tisi Baña M, de Ataide EC, Hoyos Duque S, Marciano S, Varón A, Anders M, Zerega A, Menéndez J, Zapata R, Muñoz L, Padilla Machaca M, Soza A, McCormack L, Poniachik J, Podestá LG, Gadano A, Boin IS, Duvoux C, Silva M; Latin American Liver Research, Education and Awareness Network (LALREAN).

Liver Int. 2016 Nov;36(11):1657-1667. doi: 10.1111/liv.13159. Epub 2016 Jun 15.

PMID:
27169841
13.

Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naïve Patients in Chile.

Vargas CL, Espinoza MA, Giglio A, Soza A.

PLoS One. 2015 Nov 6;10(11):e0141660. doi: 10.1371/journal.pone.0141660. eCollection 2015.

14.

[Development of MEDUC-PG14 survey to assess postgraduate teaching in medical specialties].

Pizarro M, Solís N, Rojas V, Díaz LA, Padilla O, Letelier LM, Aizman A, Sarfatis A, Olivos T, Soza A, Delfino A, Latorre G, Ivanovic-Zuvic D, Hoyl T, Bitran M, Arab JP, Riquelme A.

Rev Med Chil. 2015 Aug;143(8):1005-14. doi: 10.4067/S0034-98872015000800007. Spanish.

15.

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.

Dore GJ, Conway B, Luo Y, Janczewska E, Knysz B, Liu Y, Streinu-Cercel A, Caruntu FA, Curescu M, Skoien R, Ghesquiere W, Mazur W, Soza A, Fuster F, Greenbloom S, Motoc A, Arama V, Shaw D, Tornai I, Sasadeusz J, Dalgard O, Sullivan D, Liu X, Kapoor M, Campbell A, Podsadecki T.

J Hepatol. 2016 Jan;64(1):19-28. doi: 10.1016/j.jhep.2015.08.015. Epub 2015 Aug 29.

16.

HIV through the looking glass: insights derived from Hepatitis B.

Rivera MM, Soza A, Jazwinski A, Mi L, Kleiner DE, Zhao X, Zuber C, Brust D, Hsu E, Simpson J, Hoofnagle JH, Heller T.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):123-7. doi: 10.1097/QAI.0000000000000415.

17.

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin.

Soza A, Labbé P, Arrese M, Riquelme A, Barrera F, Benítez C, Huete A, Balcells ME, Labarca J.

Ann Hepatol. 2015 Jan-Feb;14(1):132-6.

18.

Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

Arab JP, Candia R, Zapata R, Muñoz C, Arancibia JP, Poniachik J, Soza A, Fuster F, Brahm J, Sanhueza E, Contreras J, Cuellar MC, Arrese M, Riquelme A.

World J Gastroenterol. 2014 Sep 14;20(34):12182-201. doi: 10.3748/wjg.v20.i34.12182. Review.

19.

Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

Méndez-Sánchez N, Paraná R, Cheinquer H, Alves de Mattos A, Gadano A, Silva M, Pessôa MG, Gomes-Ferraz ML, Soza A, Mendes-Correa MC, Chávez-Tapia NC, Dagher L, Padilla M, Hernandez N, Sánchez-Avila JF, Contreras F, Moraes-Coelho HS, Parise ER, Bessone F, Uribe M; Latin American Association for the Study of the Liver.

Ann Hepatol. 2014 Aug;13 Suppl 2:s4-66. Review. No abstract available.

20.

Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis.

Norero B, Pérez-Ayuso RM, Duarte I, Ramirez P, Soza A, Arrese M, Benítez C.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):142-9.

Supplemental Content

Loading ...
Support Center